loading...

COA Instruments Distributed by Mapi Research Trust

default distrib

FLIE / Functional Living Index - Emesis Functional Living Index - Emesis

Lindley C et al.

To assess the impact of chemotherapy-induced nausea and vomiting on patient's daily function

Therapeutic indications : Generic for Neoplasms

default distrib

FPS-R / Faces Pain Scale - Revised version Faces Pain Scale - Revised version

Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B et al.

To measure intensity of pain in children

Therapeutic indications : Pain

default distrib

FSFI / Female Sexual Function Index Female Sexual Function Index

Rosen RC et al.

To measure female sexual arousal and other domains of sexual functioning in women

Therapeutic indications : Female Sexuality

default distrib

GALES / The Geriatric Adverse Life Events Scale The Geriatric Adverse Life Events Scale

Devanand DP, Kim MK, Paykina N, Sackeim HA et al.

To evaluate adverse life events in elderly subjects

Therapeutic indications : Aging, Depressive disorder, Depression

default distrib

GCSI / Gastroparesis Cardinal Symptom Index Gastroparesis Cardinal Symptom Index

Janssen Global Services, LLC (USA) et al.

To assess the severity of patient-reported gastroparesis symptoms, for use in clinical trials

Therapeutic indications : Gastroparesis

default distrib

GHQ / General Health Questionnaire General Health Questionnaire

Goldberg D et al.

Screening instrument to detect psychiatric disorders in community settings and non-psychiatric clinical settings, such as primary care or general practice

Therapeutic indications : Anxiety Disorders, Depression

default distrib

GIQLI / Gastrointestinal Quality of Life index Gastrointestinal Quality of Life index

Eypasch E et al.

To assess quality of life specific for the gastrointestinal tract

Therapeutic indications : Gastrointestinal Diseases

default distrib

GIQLI-10 / Gastrointestinal Quality of Life index - 10 items Gastrointestinal Quality of Life index - 10 items

Eypasch E et al.

To assess quality of life specific for the gastrointestinal tract

Therapeutic indications : Gastrointestinal Diseases

default distrib

GIS / Global Improvement Scale Global Improvement Scale

Drossman DA et al.

To assess the impact of Irritable Bowel Syndrome

Therapeutic indications : Irritable Bowel Syndrome

default distrib

GlauQOL / Glaucoma Quality of Life Questionnaire Glaucoma Quality of Life Questionnaire

Bausch & Lomb Chauvin (France), Mapi et al.

To evaluate the impact of pathology and its treatment on the everyday life of the patient

Therapeutic indications : Glaucoma

default distrib

GME-Q / Glucose Monitoring Experiences Questionnaire Glucose Monitoring Experiences Questionnaire

Speight J, Holmes-Truscott E, Shaw J, Little SA et al.

To elicit users’ satisfaction with standard Self-Monitoring of Blood Glucose (SMBG) or Continuous Glucose Monitoring (CGM) technologies

Therapeutic indications : Diabetes Mellitus, Type 1

default distrib

GMHR / General Medical Health Rating - Version 2.0 General Medical Health Rating - Version 2.0

Lyketsos CG, Galik E, Steele C, Steinberg M, Rosenblatt A, Warren A, Sheppard JM, Baker A, Brandt J et al.

To assess medical comorbidity in dementia patients

Therapeutic indications : Dementia

default distrib

GOS / Global Overall Symptom scale Global Overall Symptom scale

Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkuns AN, Thomson AB, Mann V, Escobedo S, Chakraborty B, Nevin K et al.

To measure the overall severity of dyspepsia symptoms (defined as upper abdominal symptoms such as: epigastric pain or discomfort, heartburn, acid regurgitation, upper abdominal bloating, excessive belching, nausea, early satiety, postprandial fullness) in clinical trials and practice.

Therapeutic indications : Dyspepsia

default distrib

GSAS / Gastroesophageal Reflux Disease Symptom Assessment Scale Gastroesophageal Reflux Disease Symptom Assessment Scale

Janssen Global Services, LLC (USA) et al.

To measure frequency, severity, degree of bother for GERD symptoms

Therapeutic indications : Gastroesophageal Reflux

default distrib

HADS / Hospital Anxiety and Depression Scale Hospital Anxiety and Depression Scale

Snaith RP, Zigmond AS et al.

To detect states of anxiety and depression

Therapeutic indications : Anxiety Disorders, Depression

default distrib

HAM-A / Hamilton Anxiety Scale Hamilton Anxiety Scale

Hamilton M et al.

To measure anxiety states

Therapeutic indications : Anxiety Disorders

default distrib

HAM-D / Hamilton Depression Rating Scale Hamilton Depression Rating Scale

Hamilton M et al.

To measure severity and treatment effects in depressed patients

Therapeutic indications : Depression

default distrib

HAQ / Health Assessment Questionnaire Health Assessment Questionnaire

Fries JF et al.

To assess the difficulty in performing activities of daily living (Originally designed for adult arthritics, it has been used in a wide range of research settings)

Therapeutic indications : All, Generic for Musculoskeletal Diseases

default distrib

HDISS-DU / Hand Disability In Systemic Sclerosis - Digital Ulcers Hand Disability In Systemic Sclerosis - Digital Ulcers

Khanna D, Poiraudeau S, Gelhorn H, Papadakis K, Perchenet L, Mattera MS, Vernon M, Mouthon L, Hunsche E et al.

To capture the full spectrum of the impact of digital ulcers in patients and also to assess key symptoms and the impact of the disease on patients’ functioning from the patient perspective

Therapeutic indications : Scleroderma, Systemic

default distrib

HypoA-Q / Hypoglycaemia Awareness Questionnaire Hypoglycaemia Awareness Questionnaire

Speight J, Barendse SM, Singh H, Little SA, Inkster B, Frier BM, Heller SR, Rutter MK, Shaw JA et al.

To assess the extent to which people with diabetes experience impaired awareness of hypoglycaemia

Therapeutic indications : Hypoglycemia, Diabetes Mellitus, Type 1